Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Poole

Showing results (281-290 of 302) with videos related to

Pageof 31
Sort By:
Heart Rhythm|November 12, 2021
Clinical performance of implantable cardioverter-defibrillator lead monitoring diagnosticsJeanne E Poole, Charles D Swerdlow, Khaldoun G Tarakji, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2022
A wearable cardioverter defibrillator with a low false alarm rateJeanne E Poole, Marye J Gleva, Ulrika Birgersdotter-Green, et al.
Journal of Cardiovascular Electrophysiology|January 22, 1998
Low-energy impedance-compensating biphasic waveforms terminate ventricular fibrillation at high rates in victims of out-of-hospital cardiac arrest. LIFE InvestigatorsJ E Poole, R D White, K G Kanz, et al.
Heart Rhythm|March 30, 2021
Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trialSuneet Mittal, Bruce L Wilkoff, Jeanne E Poole, et al.
Journal of Cardiovascular Electrophysiology|July 27, 2017
Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT IIEmily P Zeitler, Sana M Al-Khatib, Daniel J Friedman, et al.
Heart Rhythm|February 23, 2020
The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-upSuneet Mittal, Bruce L Wilkoff, Charles Kennergren, et al.
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
Circulation Research|February 17, 2022
Arrhythmias in Female Patients: Incidence, Presentation and ManagementEmily P Zeitler, Jeanne E Poole, Christine M Albert, et al.
Heart Rhythm|April 25, 2026
HRS Position Statement: Changing the Tide in CPR and AED Education for Students in the United StatesRakesh Gopinathannair, Sana M Al-Khatib, Nazem Akoum, et al.
American Heart Journal|September 11, 2017
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trialsDaniel J Friedman, Sana M Al-Khatib, Emily P Zeitler, et al.
Pageof 31

Showing results (281-290 of 302) with videos related to

Sort By:
Pageof 31
Heart Rhythm|November 12, 2021
Clinical performance of implantable cardioverter-defibrillator lead monitoring diagnosticsJeanne E Poole, Charles D Swerdlow, Khaldoun G Tarakji, et al.
Journal of Cardiovascular Electrophysiology|February 17, 2022
A wearable cardioverter defibrillator with a low false alarm rateJeanne E Poole, Marye J Gleva, Ulrika Birgersdotter-Green, et al.
Journal of Cardiovascular Electrophysiology|January 22, 1998
Low-energy impedance-compensating biphasic waveforms terminate ventricular fibrillation at high rates in victims of out-of-hospital cardiac arrest. LIFE InvestigatorsJ E Poole, R D White, K G Kanz, et al.
Heart Rhythm|March 30, 2021
Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trialSuneet Mittal, Bruce L Wilkoff, Jeanne E Poole, et al.
Journal of Cardiovascular Electrophysiology|July 27, 2017
Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT IIEmily P Zeitler, Sana M Al-Khatib, Daniel J Friedman, et al.
Heart Rhythm|February 23, 2020
The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-upSuneet Mittal, Bruce L Wilkoff, Charles Kennergren, et al.
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
Circulation Research|February 17, 2022
Arrhythmias in Female Patients: Incidence, Presentation and ManagementEmily P Zeitler, Jeanne E Poole, Christine M Albert, et al.
Heart Rhythm|April 25, 2026
HRS Position Statement: Changing the Tide in CPR and AED Education for Students in the United StatesRakesh Gopinathannair, Sana M Al-Khatib, Nazem Akoum, et al.
American Heart Journal|September 11, 2017
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trialsDaniel J Friedman, Sana M Al-Khatib, Emily P Zeitler, et al.
Pageof 31